Abstract
The mean half life of doxycycline given to seven patients on long-term diphenylhydantoin treatment was 7·2 ± 0·4 hours. In five patients on long-term carbamazepine treatment the half life was 8·4 ± 1·4 hours. In four patients on combined diphenylhydantoin and carbamazepine treatment the half life was 7·4 ± 0·7 hours. All these were significantly shorter than a mean half life of 15·1 ± 1·0 hours when doxycycline was given to nine control patients. Therefore doxycycline in normal doses given to patients taking diphenylhydantoin or carbamazepine may fail to maintain the minimum inhibitory concentration necessary for proper bacteriostasis. When doxycycline is given in association with agents known to induce drug metabolism the serum concentration of the antibiotic should be watched to see that bacteriostatic levels are maintained.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Breckenridge A., Orme M. L., Davies L., Thorgeirsson S. S., Davies D. S. Dose-dependent enzyme induction. Clin Pharmacol Ther. 1973 Jul-Aug;14(4):514–520. doi: 10.1002/cpt1973144part1514. [DOI] [PubMed] [Google Scholar]
- Breckenridge A., Orme M. Clinical implications of enzyme induction. Ann N Y Acad Sci. 1971 Jul 6;179:421–431. doi: 10.1111/j.1749-6632.1971.tb46919.x. [DOI] [PubMed] [Google Scholar]
- Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacol Rev. 1967 Sep;19(3):317–366. [PubMed] [Google Scholar]
- Hansen J. M., Kristensen M., Skovsted L. Sulthiame (Ospolot) as inhibitor of diphenylhydatoin metabolism. Epilepsia. 1968 Mar;9(1):17–22. doi: 10.1111/j.1528-1157.1968.tb04954.x. [DOI] [PubMed] [Google Scholar]
- Hansen J. M., Siersboek-Nielsen K., Skovsted L. Carbamazepine-induced acceleration of diphenylhydantoin and warfarin metabolism in man. Clin Pharmacol Ther. 1971 May-Jun;12(3):539–543. doi: 10.1002/cpt1971123539. [DOI] [PubMed] [Google Scholar]
- Neuvonen P. J., Penttilä O. Interaction between doxycycline and barbiturates. Br Med J. 1974 Mar 23;1(5907):535–536. doi: 10.1136/bmj.1.5907.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Prescott L. F. Clinically important drug interactions. Drugs. 1973;5(3):161–186. doi: 10.2165/00003495-197305030-00001. [DOI] [PubMed] [Google Scholar]